Literature DB >> 15963938

Synthesis and characterization of fluorescent ubiquitin derivatives as highly sensitive substrates for the deubiquitinating enzymes UCH-L3 and USP-2.

Aline Tirat1, Alain Schilb, Virginie Riou, Lukas Leder, Bernd Gerhartz, Johann Zimmermann, Susanne Worpenberg, Ulf Eidhoff, Felix Freuler, Thomas Stettler, Lorenz Mayr, Johannes Ottl, Beate Leuenberger, Ireos Filipuzzi.   

Abstract

Deubiquitinating enzymes (DUBs) catalyze the removal of attached ubiquitin molecules from amino groups of target proteins. The large family of DUBs plays an important role in the regulation of the intracellular homeostasis of different proteins and influences therefore key events such as cell division, apoptosis, etc. The DUB family members UCH-L3 and USP2 are believed to inhibit the degradation of various tumor-growth-promoting proteins by removing the trigger for degradation. Inhibitors of these enzymes should therefore lead to enhanced degradation of oncoproteins and may thus stop tumor growth. To develop an enzymatic assay for the search of UCH-L3 and USP2 inhibitors, C-terminally labeled ubiquitin substrates were enzymatically synthesized. We have used the ubiquitin-activating enzyme E1 and one of the ubiquitin-conjugating enzymes E2 to attach a fluorescent lysine derivative to the C terminus of ubiquitin. Since only the epsilon-NH(2) group of the lysine derivatives was free and reactive, the conjugates closely mimic the isopeptide bond between the ubiquitin and the lysine side chains of the targeted proteins. Various substrates were synthesized by this approach and characterized enzymatically with the two DUBs. The variant consisting of the fusion protein between the large N-terminal NusA tag and the ubiquitin which was modified with alpha-NH(2)-tetramethylrhodamin-lysine, was found to give the highest dynamic range in a fluorescence polarization readout. Therefore we have chosen this substrate for the development of a miniaturized, fluorescence-polarization-based high-throughput screening assay.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15963938     DOI: 10.1016/j.ab.2005.04.023

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  14 in total

1.  Characterization of selective ubiquitin and ubiquitin-like protease inhibitors using a fluorescence-based multiplex assay format.

Authors:  Xufan Tian; Nigora S Isamiddinova; Raymond J Peroutka; Seth J Goldenberg; Michael R Mattern; Benjamin Nicholson; Craig Leach
Journal:  Assay Drug Dev Technol       Date:  2010-12-06       Impact factor: 1.738

Review 2.  Strategies for the identification of novel inhibitors of deubiquitinating enzymes.

Authors:  Seth J Goldenberg; Jeffrey L McDermott; Tauseef R Butt; Michael R Mattern; Benjamin Nicholson
Journal:  Biochem Soc Trans       Date:  2008-10       Impact factor: 5.407

Review 3.  The role of deubiquitinases in breast cancer.

Authors:  Zhenna Xiao; Peijing Zhang; Li Ma
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

4.  Positive symptoms of psychosis correlate with expression of ubiquitin proteasome genes in peripheral blood.

Authors:  Chad A Bousman; Gursharan Chana; Stephen J Glatt; Sharon D Chandler; Todd May; James Lohr; William S Kremen; Ming T Tsuang; Ian P Everall
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-10-05       Impact factor: 3.568

5.  High-throughput caveolar proteomic signature profile for maternal binge alcohol consumption.

Authors:  Jayanth Ramadoss; Wu-xiang Liao; Dong-bao Chen; Ronald R Magness
Journal:  Alcohol       Date:  2010-01-06       Impact factor: 2.405

6.  A fluorescence polarization-based competition assay for measuring interactions between unlabeled ubiquitin chains and UCH37•RPN13.

Authors:  Jiale Du; Eric R Strieter
Journal:  Anal Biochem       Date:  2018-04-23       Impact factor: 3.365

Review 7.  Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors.

Authors:  Shiyao Chen; Yunqi Liu; Huchen Zhou
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

8.  A general chemical ligation approach towards isopeptide-linked ubiquitin and ubiquitin-like assay reagents.

Authors:  Paul P Geurink; Farid El Oualid; Anika Jonker; Dharjath S Hameed; Huib Ovaa
Journal:  Chembiochem       Date:  2011-12-23       Impact factor: 3.164

9.  Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities.

Authors:  Benjamin Nicholson; Craig A Leach; Seth J Goldenberg; Dana M Francis; Matthew P Kodrasov; Xufan Tian; John Shanks; David E Sterner; Alejandro Bernal; Michael R Mattern; Keith D Wilkinson; Tauseef R Butt
Journal:  Protein Sci       Date:  2008-04-18       Impact factor: 6.725

Review 10.  The 26S proteasome is a multifaceted target for anti-cancer therapies.

Authors:  Tatyana A Grigoreva; Vyacheslav G Tribulovich; Alexander V Garabadzhiu; Gerry Melino; Nickolai A Barlev
Journal:  Oncotarget       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.